SAREPTA THERAPEUTICS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of SRPT for the last quarter is 9.20 B MXN, and it's 38.28% higher compared to the previous quarter. The net income of Q3 24 is 662.26 M MXN.